Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Baird Medical Investment Holdings Limited (BDMDW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: BDMDW (1-star) is a SELL. SELL since 5 days. Profits (-50.00%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -50% | Avg. Invested days 46 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 6963 | Beta -0.7 | 52 Weeks Range 0.02 - 0.20 | Updated Date 02/26/2025 |
52 Weeks Range 0.02 - 0.20 | Updated Date 02/26/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 37.96% | Operating Margin (TTM) 38.74% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 10638416 |
Shares Outstanding - | Shares Floating 10638416 | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Baird Medical Investment Holdings Limited
Company Overview
History and Background
Baird Medical Investment Holdings Limited is a medical investment group, primarily focused on China's growing healthcare market. While specific founding year and milestones are difficult to ascertain from publicly available US sources, its existence as a US stock implies operations and investments related to US markets. Specific details require access to proprietary financial databases.
Core Business Areas
- Medical Investment: Investing in and managing medical-related ventures, including medical device companies, pharmaceuticals, and healthcare service providers. Focused primarily on opportunities in China but also potentially holding US-based assets.
Leadership and Structure
Leadership details are difficult to obtain from publicly available US sources. Information about the organizational structure is also not readily available.
Top Products and Market Share
Key Offerings
- Medical Investments: Baird Medical invests in a range of medical ventures. Market share data depends on the specific investments and is difficult to quantify directly. Competitors would include other venture capital and private equity firms specializing in the healthcare sector.
Market Dynamics
Industry Overview
The healthcare market, especially in China, is experiencing significant growth driven by an aging population, increasing affluence, and government initiatives to improve healthcare access. The US healthcare market is also substantial and growing, albeit at a different rate.
Positioning
Baird Medical positions itself as an investor in the growing medical sector. Competitive advantages depend on the specific portfolio companies and investment strategies. Given the opaque structure of the company from a US perspective, it's difficult to ascertain the exact advantage.
Total Addressable Market (TAM)
The global healthcare market is valued in the trillions of USD. China's market is one of the largest and fastest-growing. Baird Medical's position within this TAM depends on the size and success of its investments.
Upturn SWOT Analysis
Strengths
- Access to Investment Capital
- Investment Expertise
- Potential Network within the Medical Field
Weaknesses
- Lack of Public Transparency
- Limited Public Information on Specific Investments
- Regulatory Risk Related to China Investments
- Potential Geopolitical Risk
Opportunities
- Growth in the Chinese Healthcare Market
- Expansion into New Medical Technologies
- Strategic Partnerships with Leading Medical Companies
- Capitalize on Healthcare Reform Initiatives
Threats
- Intense Competition in the Investment Sector
- Changes in Healthcare Regulations
- Economic Downturn Impacting Investment Returns
- Geopolitical Instability Between US and China
Competitors and Market Share
Key Competitors
Competitive Landscape
Not possible to evaluate without financial data and competitive information.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Not possible to determine without financial data.
Future Projections: Not possible to provide without financial data and analyst coverage.
Recent Initiatives: Information on recent initiatives is not publicly available.
Summary
Due to a lack of publicly accessible financial and operational data from US sources, a thorough analysis of Baird Medical Investment Holdings Limited is not possible. Its strength lies in its potential access to the growing Chinese healthcare market, but limited transparency and geopolitical risks are concerns. More data is required for an accurate assessment.
Similar Companies
Sources and Disclaimers
Data Sources:
- Publicly available information. Due to limited data accessible from US sources, the analysis is constrained.
Disclaimers:
The information provided is based on limited publicly available data and should not be considered investment advice. A comprehensive analysis requires access to proprietary financial databases and company-specific information.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Baird Medical Investment Holdings Limited
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2024-10-02 | Chairwoman of the Board of Directors & CEO Ms. Haimei Wu | ||
Sector Healthcare | Industry Medical Devices | Full time employees 148 | Website https://www.bairdmed.com |
Full time employees 148 | Website https://www.bairdmed.com | ||
Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China and the United States. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.